VEGF Protein (Human Recombinant)

<strong>VEGF Protein (Human Recombinant)</strong>_x000D_ <strong>Catalog number:</strong> B2010563_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> Full length_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular in the study of various cellular systems as well as VEGF proliferation assays_x000D_ <strong>Storage:</strong> −70°C_x000D_ <strong>Keywords:</strong> Vascular endothelial growth factor_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Melincovici CS, Boşca AB, Şuşman S, Mărginean M, Mihu C, Istrate M, Moldovan_x000D_ IM, Roman AL, Mihu CM. Vascular endothelial growth factor (VEGF) - key factor in_x000D_ normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455-467._x000D_ _x000D_ 2: Apte RS, Chen DS, Ferrara N. VEGF_ in Signaling and Disease: Beyond Discovery_x000D_ and Development. Cell. 2019 Mar 7;176(6):1248-1264._x000D_ _x000D_ 3: Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology._x000D_ 2005;69 Suppl 3:4-10._x000D_ _x000D_ 4: Itatani Y, Kawada K, Yamamoto T, Sakai Y. Resistance to Anti-Angiogenic_x000D_ Therapy in Cancer-Alterations to Anti-VEGF_ Pathway. Int J Mol Sci. 2018 Apr_x000D_ 18;19(4):1232._x000D_ _x000D_ 5: Porta M, Striglia E. Intravitreal anti-VEGF_ agents and cardiovascular risk._x000D_ Intern Emerg Med. 2020 Mar;15(2):199-210._x000D_ _x000D_ 6: Matsumoto K, Ema M. Roles of VEGF-A signalling in development, regeneration,_x000D_ and tumours. J Biochem. 2014 Jul;156(1):1-10._x000D_ _x000D_ 7: Theis V, Theiss C. VEGF - A Stimulus for Neuronal Development and_x000D_ Regeneration in the CNS and PNS. Curr Protein Pept Sci. 2018;19(6):589-597._x000D_ _x000D_ 8: Yang S, Zhao J, Sun X. Resistance to anti-VEGF_ therapy in neovascular age-_x000D_ related macular degeneration: a comprehensive review. Drug Des Devel Ther. 2016_x000D_ Jun 2;10:1857-67._x000D_ _x000D_ 9: Peng K, Bai Y, Zhu Q, Hu B, Xu Y. Targeting VEGF-neuropilin interactions: a_x000D_ promising antitumor strategy. Drug Discov Today. 2019 Feb;24(2):656-664._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/30025088/">10: Sant DW, Camarena V, Mustafi S, Li Y, Wilkes Z, Van Booven D, Wen R, Wang G._x000D_ Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells. Invest_x000D_ Ophthalmol Vis Sci. 2018 Jul 2;59(8):3608-3618. </a>_x000D_ _x000D_ <strong>Products Related to VEGF Protein (Human Recombinant)</strong><a href="https://moleculardepot.com/product-category/Proteins/">: Proteins</a>